| |
|
|
|
Acasti Pharma Inc.  
|
|
1.05 -0.02 (-0.02%) |
03-22 16:00 |
|
Open: |
1.05 |
Pre close: |
1.07 |
Target:
|
1.31
|
|
High: |
1.0699 |
Low: |
1.03 |
Resistance:
|
1.12
1.31
|
|
Volume: |
368,530 |
Market Cap: |
82M |
Support:
|
0.98
 0.89
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.06
 |
MACD |
MACD(12,26):
|
0.02 |
|
MA(20): |
1.06 |
Signal(12,26,9): |
0.02 |
|
MA(100): |
0.92 |
Stochastic Oscillator |
%K(14,3):
|
52.78 |
|
MA(250): |
0.83 |
%D(3): |
55.56 |
|
Average Volume(K) |
3-Month: |
36616
|
52-Week |
High:
|
1.80 |
|
10-Days: |
28716 |
Low: |
0.43 |
|
RSI |
RSI(14):
|
52.24 |
Change(%): |
5.0 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
-187.1 |
Shares Out. (M) |
78.13 |
|
EPS Est. Current Year |
-0.730 |
Return on Assets (ttm) |
-98.5 |
Shares Float (M) |
78.13 |
|
EPS Est. Next Year |
-0.770 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
3.80 |
|
Forward EPS |
-0.351 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
3.600 |
EBITDA (p.s.) |
0.000 |
P/E |
0.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.29 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
0.00 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
0.00 |
P/CF |
0.00 |
|
|
|
|
|
|
